- Seroprevalence of Mycoplasma pneumoniae and Chlamydia pneumoniae in Stable Asthma and Chronic Obstructive Pulmonary Disease
-
Park SJ, Lee YC, Rhee YK, Lee HB
- KMID: 1095194
- J Korean Med Sci.
- 2005 Apr;20(2):225-228.
- doi: 10.3346/jkms.2005.20.2.225
Mycoplasma pneumoniae and Chlamydia pneumoniae have been suggested to take part in the acute exacerbation of bronchial asthma and chronic obstructive pulmonary disease (COPD). Several studies have questioned whether they... -
- CITED
-
- Close
- SHARE
-
- Close
- Upregulation of extracellular matrix metalloproteinase inducer (EMMPRIN) and gelatinases in human atherosclerosis infected with Chlamydia pneumoniae: The potential role of Chlamydia pneumoniae infection in the progression of atherosclerosis
-
Choi EY, Kim DS, Hong BK, Kwon HM, Song YG, Byun KH, Park HY, Whang KC, Kim HS
- KMID: 1121092
- Exp Mol Med.
- 2002 Dec;34(6):391-400.
Chlamydia pneumoniae infection implicated as an important etiologic factor of atherosclerosis, especially in coronary artery disease (CAD), was found in vitro to be associated with the induction of matrix... -
- CITED
-
- Close
- SHARE
-
- Close
- An Elevated Value of C-Reactive Protein is the Only Predictive Factor of Restenosis after Percutaneous Coronary Intervention
-
Jeong WK, Jeong MH, Kim KH, Lee SR, Park OY, Yum JH, Kim JH, Kim W, Rhew JY, Ahn YK, Cho JG, Ahn BH, Suh SP, Park JC, Kim SH, Kang JC
- KMID: 759654
- Korean J Intern Med.
- 2003 Sep;18(3):154-160.
BACKGROUND: The current techniques for percutaneous coronary interventions (PCI) remain limited by restenosis. Recent studies have provided evidence of inflammation playing a role in the pathogenesis of cardiovascular disease. METHODS:... -
- CITED
-
- Close
- SHARE
-
- Close
